PBH
What one share of Prestige Consumer Healthcare holds
Pharmaceutical Preparations
We formed as a Delaware corporation in 1996 and are engaged in the development, manufacturing, marketing, sales and distribution of well-recognized, brand name, over-the-counter (“OTC”) health and personal care products to mass merchandisers, drug/drug wholesale, food, dollar, convenience and club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets.
Prestige Consumer Healthcare’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $22.94 |
|---|---|
| Profit | $3.57 |
| Capex (buildings and equipment) | $0.29 |
| Free cash flow | $4.89 |
| Cash and investments | $1.88 |
| Debt | $43.01 |
| Book value | $40.46 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $16.53 | $1.30 | $0.06 | $2.73 | — | $15.53 |
| 2018 | $19.45 | $6.34 | $0.23 | $3.69 | — | $22.21 |
| 2019 | $18.74 | −$0.69 | $0.20 | $3.43 | — | $21.16 |
| 2020 | $18.83 | $2.78 | $0.28 | $3.96 | — | $23.38 |
| 2021 | $18.64 | $3.25 | $0.44 | $4.22 | — | $27.21 |
| 2022 | $21.38 | $4.04 | $0.19 | $4.92 | — | $31.38 |
| 2023 | $22.60 | −$1.65 | $0.16 | $4.45 | — | $29.12 |
| 2024 | $22.43 | $4.17 | $0.19 | $4.77 | — | $33.16 |
| 2025 | $22.72 | $4.29 | $0.16 | $4.86 | — | $37.13 |
| 2026 | $22.35 | $3.91 | $0.23 | $5.06 | — | $39.84 |